DARE: Dare Bioscience, Inc. Common Stock Company Profile & Statistics

Dare Bioscience, Inc. Common Stock Profile

About

Dare Bioscience, Inc. is a healthcare company. It involved in the development and commercialization of products in women's reproductive health. Dare Bioscience, Inc., formerly known as Cerulean Pharma Inc., is based in SAN DIEGO.

Info & Links

CEO

Sabrina Martucci Johnson

Headquarters

3655 NOBEL DRIVE, SUITE 260
SAN DIEGO, CA 92122, UNITED STATES

Auditor

Haskell & White LLP

Share holders

Employees

Dare Bioscience, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

30.58M

Enterprise Value

9.54M

Enterprise Value/EBITDA(ttm)

-0.59

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

15.88

Price to Book(mrq)

9.86

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

Profit Margin(ttm)

-36775.51%

Return on Equity(ttm)

Return on Invested Capital(ttm)

54.81%

Return on Assets(ttm)

-82.71%

Income Statement

Revenue(ttm)

-57.10K

Revenue Per Share(ttm)

-0.00

Gross Profit(ttm)

-57.10K

EBITDA(ttm)³

-16.25M

Net Income Available to Common(ttm)

-17.46M

Diluted EPS(ttm)

-1.87

Share Statistics

Beta (5Y Monthly)

0.77

52-Week Change

-21.03%

S&P 500 52-Week Change

15.41%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

14.29M

Dividend Yield

0.00%

Float⁴

13.60M

% Held by Insiders

4.80%

% Held by Institutions

6.70%

Balance Sheet

Total Cash(mrq)

23.08M

Total Cash Per Share(mrq)

1.61

Total Debt(mrq)

2.03M

Total Debt/Equity(mrq)

71.20%

Current Ratio(mrq)

1.18%

Quick Ratio(mrq)

1.18%

Book Value Per Share(mrq)

0.21

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.89

Free Cash Flow(ytd)

-11.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

DARE

Dare Bioscience, Inc. Common Stock